250 related articles for article (PubMed ID: 24569607)
1. Cell therapy using retinal progenitor cells shows therapeutic effect in a chemically-induced rotenone mouse model of Leber hereditary optic neuropathy.
Mansergh FC; Chadderton N; Kenna PF; Gobbo OL; Farrar GJ
Eur J Hum Genet; 2014 Nov; 22(11):1314-20. PubMed ID: 24569607
[TBL] [Abstract][Full Text] [Related]
2. Intravitreal delivery of AAV-NDI1 provides functional benefit in a murine model of Leber hereditary optic neuropathy.
Chadderton N; Palfi A; Millington-Ward S; Gobbo O; Overlack N; Carrigan M; O'Reilly M; Campbell M; Ehrhardt C; Wolfrum U; Humphries P; Kenna PF; Farrar GJ
Eur J Hum Genet; 2013 Jan; 21(1):62-8. PubMed ID: 22669418
[TBL] [Abstract][Full Text] [Related]
3. Successful amelioration of mitochondrial optic neuropathy using the yeast NDI1 gene in a rat animal model.
Marella M; Seo BB; Thomas BB; Matsuno-Yagi A; Yagi T
PLoS One; 2010 Jul; 5(7):e11472. PubMed ID: 20628600
[TBL] [Abstract][Full Text] [Related]
4. Partial mitochondrial complex I inhibition induces oxidative damage and perturbs glutamate transport in primary retinal cultures. Relevance to Leber Hereditary Optic Neuropathy (LHON).
Beretta S; Wood JP; Derham B; Sala G; Tremolizzo L; Ferrarese C; Osborne NN
Neurobiol Dis; 2006 Nov; 24(2):308-17. PubMed ID: 16959493
[TBL] [Abstract][Full Text] [Related]
5. Involvement of endoplasmic reticulum stress in rotenone-induced leber hereditary optic neuropathy model and the discovery of new therapeutic agents.
Aoyama Y; Inagaki S; Aoshima K; Iwata Y; Nakamura S; Hara H; Shimazawa M
J Pharmacol Sci; 2021 Oct; 147(2):200-207. PubMed ID: 34384568
[TBL] [Abstract][Full Text] [Related]
6. Idebenone protects against retinal damage and loss of vision in a mouse model of Leber's hereditary optic neuropathy.
Heitz FD; Erb M; Anklin C; Robay D; Pernet V; Gueven N
PLoS One; 2012; 7(9):e45182. PubMed ID: 23028832
[TBL] [Abstract][Full Text] [Related]
7. Mutant NADH dehydrogenase subunit 4 gene delivery to mitochondria by targeting sequence-modified adeno-associated virus induces visual loss and optic atrophy in mice.
Yu H; Ozdemir SS; Koilkonda RD; Chou TH; Porciatti V; Chiodo V; Boye SL; Hauswirth WW; Lewin AS; Guy J
Mol Vis; 2012; 18():1668-83. PubMed ID: 22773905
[TBL] [Abstract][Full Text] [Related]
8. Prophylactic nicotinamide treatment protects from rotenone-induced neurodegeneration by increasing mitochondrial content and volume.
Otmani A; Jóhannesson G; Brautaset R; Tribble JR; Williams PA
Acta Neuropathol Commun; 2024 Mar; 12(1):37. PubMed ID: 38429841
[TBL] [Abstract][Full Text] [Related]
9. Safety and effects of the vector for the Leber hereditary optic neuropathy gene therapy clinical trial.
Koilkonda RD; Yu H; Chou TH; Feuer WJ; Ruggeri M; Porciatti V; Tse D; Hauswirth WW; Chiodo V; Boye SL; Lewin AS; Neuringer M; Renner L; Guy J
JAMA Ophthalmol; 2014 Apr; 132(4):409-20. PubMed ID: 24457989
[TBL] [Abstract][Full Text] [Related]
10. XIAP Protects Retinal Ganglion Cells in the Mutant ND4 Mouse Model of Leber Hereditary Optic Neuropathy.
Wassmer SJ; De Repentigny Y; Sheppard D; Lagali PS; Fang L; Coupland SG; Kothary R; Guy J; Hauswirth WW; Tsilfidis C
Invest Ophthalmol Vis Sci; 2020 Jul; 61(8):49. PubMed ID: 32735323
[TBL] [Abstract][Full Text] [Related]
11. Leber hereditary optic neuropathy-new insights and old challenges.
Sundaramurthy S; SelvaKumar A; Ching J; Dharani V; Sarangapani S; Yu-Wai-Man P
Graefes Arch Clin Exp Ophthalmol; 2021 Sep; 259(9):2461-2472. PubMed ID: 33185731
[TBL] [Abstract][Full Text] [Related]
12. HLA-Homozygous iPSC-Derived Mesenchymal Stem Cells Rescue Rotenone-Induced Experimental Leber's Hereditary Optic Neuropathy-like Models In Vitro and In Vivo.
Tsai ET; Peng SY; Wu YR; Lin TC; Chen CY; Liu YH; Tseng YH; Hsiao YJ; Tseng HC; Lai WY; Lin YY; Yang YP; Chiou SH; Chen SP; Chien Y
Cells; 2023 Nov; 12(22):. PubMed ID: 37998352
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial transport mediates survival of retinal ganglion cells in affected LHON patients.
Yang TC; Yarmishyn AA; Yang YP; Lu PC; Chou SJ; Wang ML; Lin TC; Hwang DK; Chou YB; Chen SJ; Yu WK; Wang AG; Hsu CC; Chiou SH
Hum Mol Genet; 2020 Jun; 29(9):1454-1464. PubMed ID: 32277753
[TBL] [Abstract][Full Text] [Related]
14. Emerging Mitochondrial Therapeutic Targets in Optic Neuropathies.
Lopez Sanchez MI; Crowston JG; Mackey DA; Trounce IA
Pharmacol Ther; 2016 Sep; 165():132-52. PubMed ID: 27288727
[TBL] [Abstract][Full Text] [Related]
15. [Clinical research progress of gene therapy for Leber hereditary optic neuropathy].
Wu YJ; Li WS
Zhonghua Yan Ke Za Zhi; 2018 Aug; 54(8):636-640. PubMed ID: 30107658
[TBL] [Abstract][Full Text] [Related]
16. The mutant human ND4 subunit of complex I induces optic neuropathy in the mouse.
Qi X; Sun L; Lewin AS; Hauswirth WW; Guy J
Invest Ophthalmol Vis Sci; 2007 Jan; 48(1):1-10. PubMed ID: 17197509
[TBL] [Abstract][Full Text] [Related]
17. Leber hereditary optic neuropathy gene therapy clinical trial recruitment: year 1.
Lam BL; Feuer WJ; Abukhalil F; Porciatti V; Hauswirth WW; Guy J
Arch Ophthalmol; 2010 Sep; 128(9):1129-35. PubMed ID: 20837795
[TBL] [Abstract][Full Text] [Related]
18. Gene therapy restores mitochondrial function and protects retinal ganglion cells in optic neuropathy induced by a mito-targeted mutant ND1 gene.
Liu Y; Eastwood JD; Alba DE; Velmurugan S; Sun N; Porciatti V; Lee RK; Hauswirth WW; Guy J; Yu H
Gene Ther; 2022 Jun; 29(6):368-378. PubMed ID: 35383288
[TBL] [Abstract][Full Text] [Related]
19. Leber hereditary optic neuropathy: respiratory chain dysfunction and degeneration of the optic nerve.
Howell N
Vision Res; 1998 May; 38(10):1495-504. PubMed ID: 9667014
[TBL] [Abstract][Full Text] [Related]
20. Trial end points and natural history in patients with G11778A Leber hereditary optic neuropathy : preparation for gene therapy clinical trial.
Lam BL; Feuer WJ; Schiffman JC; Porciatti V; Vandenbroucke R; Rosa PR; Gregori G; Guy J
JAMA Ophthalmol; 2014 Apr; 132(4):428-36. PubMed ID: 24525545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
